← TrialMatch
HomeTrials

The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophre

Schizophrenia is a chronic, recurrent and disabling illness that usually lasts a lifetime and causes serious problems in quality of life and functioning. Psychoeducation programmes added to drug treatment in the treatment of schizophrenia have been shown to increase the knowledge of patients and their relatives about t

Condition(s)Schizophrenia Disorders
StatusRecruiting
PhaseNA
Study typeInterventional
SummarySchizophrenia is a chronic, recurrent and disabling illness that usually lasts a lifetime and causes serious problems in quality of life and functioning. Psychoeducation programmes added to drug treatment in the treatment of schizophrenia have been shown to increase the knowledge of patients and their relatives about the disease, coping skills, prevention of exacerbations and relapses of the disease, social functioning, insight into the disease, compliance with drug treatment and quality of life. Rehabilitated individuals diagnosed with schizophrenia who are registered and continuing at Kastamonu Training and Research Community Mental Health Centre will constitute the population, and individuals who continue between April 2024 and May 2024 will constitute the sample. The research will be c
Who can participateInclusion Criteria: 1. Having been diagnosed with schizophrenia 2. TRSM registered and continuing 3. Acceptance to work and training Exclusion Criteria: 1. Have not been diagnosed with schizophrenia 2. If he/she does not agree to participate in the study 3. If not registered with TRSM
Ages18 Years
SexAll
Lead sponsorKastamonu University
LocationsKastamonu, Central, Turkey (Türkiye)
Start date2025-02-14
NCT IDNCT06882538
Official listinghttps://clinicaltrials.gov/study/NCT06882538

🔍 Search all trials →